MedPath

aryxmask Supreme * or endotracheal tube in adults with cardiac arrest in prehospital care: a Randmised Controlled Trial

Recruiting
Conditions
cardiac arrest
10007521
Registration Number
NL-OMON34188
Lead Sponsor
Connexxion Ambulancezorg
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
200
Inclusion Criteria

Adults with cardiac arrest

Exclusion Criteria

Trauma patients
Patients with a trachaestoma

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Primary outcome measures<br /><br>* Effectiveness will be displayed in seconds of placing (LMA Supreme*)<br /><br>* The primary success rate when a secure airway was established (proven CO2<br /><br>exchange)<br /><br><br /><br>Research question<br /><br>What is the difference in safety and effectiveness between resuscitation with<br /><br>LMA Supreme* and ETI performed by emergency nurses?</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary outcome measures<br /><br>a. Aspiration<br /><br>b. apparent damage to the glottis / throat<br /><br>c. cuff pressure ETI too high (over 30 cm H2O)<br /><br>d. inability to create a free airway (more than 3 placement attempts)<br /><br><br /><br>Research questions<br /><br>1. What adverse events occure in ETI performed by ambulance nurses in CAZ NOG?<br /><br>2. What adverse events occur when using LMA Supreme* performed by ambulance<br /><br>nurses in CAZ NOG?</p><br>
© Copyright 2025. All Rights Reserved by MedPath